[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363790-105":59,"doc-detail-363790-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multimodal-modeling-based-on-dna-methylation-analysis-in-bronchoalveolar-lavage-fluid-for-early-lung-cancer-detection","Multimodal modeling based on DNA methylation analysis in bronchoalveolar lavage fluid for early lung cancer detection","","Early lung cancer detection remains challenging, motivating improved diagnostic positivity and accuracy. A prospective randomized diagnostic study evaluated whether bronchoalveolar lavage fluid (BALF) methylation of RASSF1A and SHOX2 genes, combined with CT imaging and tumor markers, could predict malignant lung lesions. Patients with CT-detected lung lesions were assigned to pre-biopsy or post-biopsy BALF groups, and internal validation assessed performance. Post-biopsy sampling increased gene methylation positivity and pathological cytology rates, and the multimodal model showed high AUC values for malignant masses and nodules, supporting strong predictive value.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multimodal-modeling-based-on-dna-methylation-analysis-in-bronchoalveolar-lavage-fluid-for-early-lung-cancer-detection/363790/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multimodal-modeling-based-on-dna-methylation-analysis-in-bronchoalveolar-lavage-fluid-for-early-lung-cancer-detection/363790.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What diagnostic approach does the study evaluate for early lung cancer detection?","Question",{"text":112,"@type":113},"The study evaluates a multimodal prediction model that combines BALF DNA methylation of RASSF1A and SHOX2 with CT imaging and tumor markers to predict malignant lung lesions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients assigned in the prospective diagnostic study?",{"text":117,"@type":113},"A total of 310 patients with CT-detected lung lesions were randomized 1:1 into a pre-biopsy BALF group and a post-biopsy BALF group.",{"name":119,"@type":110,"acceptedAnswer":120},"What performance did the multimodal model achieve on training and validation sets?",{"text":121,"@type":113},"In training, the model reached AUCs of 0.985 for malignant lung masses and 0.903 for lung nodules. On the validation set, AUCs were 0.930 for masses and 0.811 for nodules.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363790,1790662164,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMultimodal modeling based on DNA methylation analysis in bronchoalveolar lavage fluid for early lung cancer detection  \nJincheng Liu1,2,4, Chengyi You1,2,4, Li Bai1,2, Yangfan Lv3, Wei Zeng3, Bin Wang1,2, Wen Zhang1,2, Zansheng Huang1,2, Dongfan Ye1,2, Yuhang Guo1,2, Ping Wang1,2, Peihua Zhou1,2, Heng You1,2, Tianxiu Wu1,2, Chuangye Wang1,2, Bin Qing1,2 & Zhi Xu1,2􀀍  \nLung cancer diagnosis poses a significant clinical challenge, with emphasis on enhancing the positivity rate and accuracy of early detection. The use of bronchoalveolar lavage fluid (BALF) for detecting the methylation of ras-association domain family member 1 A (RASSF1A) and short stature homeobox 2 (SHOX2) genes has emerged as a novel molecular diagnostic technique for lung cancer. Nonetheless, this method’s positivity rate can vary due to factors such as BALF quality, and its diagnostic consistency is uncertain. It was a prospective diagnostic study with randomized sampling. In this study, 310 patients with lung lesions detected by computed tomography (CT) imaging were enrolled, and they were randomized 1:1 into pre-biopsy BALF group and post-biopsy BALF group. RASSF1A and SHOX2 methylation in BALF were detected, and CT images and tumor markers of patients were collected to develop a multimodal model based on BALF methylation for predicting malignant lung lesions. An internal validation set was employed to gauge the model’s effectiveness. The findings revealed a statistically significant increase in gene methylation positivity rate and pathological cytology rates in the post-biopsy BALF group compared to the pre-biopsy BALF group (P \u003C 0.05). The model demonstrated an area under the curve (AUC) of 0.985 for predicting malignant lung masses and 0.903 for lung nodules in the training set. When tested on the validation set, theAUC for predicting malignant lung masses and lung nodules was 0.930 and 0.811, respectively. The multimodal prediction model constructed based on RASSF1A and SHOX2 methylation of post-biopsy BALF demonstrates a high predictive value for identifying malignant lung lesions.  \nKeywords Bronchoalveolar lavage fluid, DNA methylation, Lung lesions, RASSF1A gene, SHOX2 gene  \nAmong all types of malignant tumors, lung cancer holds the highest rates of incidence and mortality globally1. According to the TNM staging system, the 5-year survival rate for patients with stage I non-small cell lung cancer (NSCLC) ranges from 68% to 92%, whereas for stage IV, it is less than 10%2,3. Consequently, increasing the rate of early detection is crucial for improving the 5-year survival rate for lung cancer patients.  \nCurrently, low-dose computed tomography (LDCT) has been extensively used for lung cancer screening, which can reduce the mortality rate among high-risk, asymptomatic lung cancer patients by 31%4. However, LDCT, with its false-positivity rate ranging from approximately 12.9% to 25.9%, is susceptible to misdiagnosis and over-treatment. Furthermore, long-term follow-up can lead to a higher cumulative radiation dose for patients5,6. The determination of whether lung lesions are benign or malignant relies on pathologic diagnosis, which is considered the gold standard. However, this process is limited by the accuracy of the sample collection and the pathologist’s personal experience7.  \nCrucial for regulating gene transcription and expression, DNA methylation involves modifying the methylation status of Cytosine-phosphate-Guanine(CpG) islands present in gene promoters8. It has been established that heightened DNA methylation of oncogenes is intricately linked to tumorigenesis and often  \n1Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital ofThird Military Medical University (Army Medical University), No. 83 Xinqiao Main Street, Shapingba District, Chongqing, China. 2Chongqing Key Laboratory of Precision Medicine and Prevention of Major Respiratory ","cbCailKlsgO6h0Lb","https://ap.wps.com/l/cbCailKlsgO6h0Lb","pdf",3422357,15,"English","# Background\n## Clinical need for early lung cancer detection\n## Limits of LDCT and pathologic diagnosis\n## Role of DNA methylation and target genes\n# Methods\n## Prospective randomized diagnostic study design\n## BALF methylation detection and multimodal model construction\n## Internal validation\n# Results\n## Positivity and cytology rate differences\n## AUC performance for masses and nodules\n# Conclusion","[{\"question\":\"What diagnostic approach does the study evaluate for early lung cancer detection?\",\"answer\":\"The study evaluates a multimodal prediction model that combines BALF DNA methylation of RASSF1A and SHOX2 with CT imaging and tumor markers to predict malignant lung lesions.\"},{\"question\":\"How were patients assigned in the prospective diagnostic study?\",\"answer\":\"A total of 310 patients with CT-detected lung lesions were randomized 1:1 into a pre-biopsy BALF group and a post-biopsy BALF group.\"},{\"question\":\"What performance did the multimodal model achieve on training and validation sets?\",\"answer\":\"In training, the model reached AUCs of 0.985 for malignant lung masses and 0.903 for lung nodules. On the validation set, AUCs were 0.930 for masses and 0.811 for nodules.\"}]","Multimodal modeling based on DNA methylation analysis in bronchoalveolar lavage fluid for early lung cancer detection | PDF",1790153160,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d01715ce3cdabc858677499706293afe.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0beccf22684629386731f268df70432.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d286dfba807ad8690c8951f6297928be.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a34a882d1cad69de77fe9cfecc97cfd3.webp",980,1287]